| Name | Enibarcimab |
|---|
| Description | Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID 2019 infections and septic shock research[1]. |
|---|---|
| Related Catalog | |
| Target |
Immunoglobulin G1[1] |
| References |
| No Any Chemical & Physical Properties |